Search Results - David B. Weiner

Refine Results
  1. 1
    DNA vaccines: developing new strategies to enhance immune responses

    DNA vaccines: developing new strategies to enhance immune responses by Shaheed Abdulhaqq, David B. Weiner

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    DNA vaccines: prime time is now

    DNA vaccines: prime time is now by E. Gary, David B. Weiner

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Developing DNA vaccines that call to dendritic cells

    Developing DNA vaccines that call to dendritic cells by Michele A. Kutzler, David B. Weiner

    Published 2004
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Enhancement of human immunodeficiency virus type 1‐DNA vaccine potency through incorporation of T‐helper 1 molecular adjuvants

    Enhancement of human immunodeficiency virus type 1‐DNA vaccine potency through incorporation of T‐helper 1 molecular adjuvants by Sandra A. Calarota, David B. Weiner

    Published 2004
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Interleukin 33: a switch-hitting cytokine

    Interleukin 33: a switch-hitting cytokine by Daniel O. Villarreal, David B. Weiner

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Electroporation delivery of DNA vaccines: prospects for success

    Electroporation delivery of DNA vaccines: prospects for success by Niranjan Y. Sardesai, David B. Weiner

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    DNA vaccines: ready for prime time?

    DNA vaccines: ready for prime time? by Michele A. Kutzler, David B. Weiner

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    DNA vaccination: antigen presentation and the induction of immunity

    DNA vaccination: antigen presentation and the induction of immunity by Devon J. Shedlock, David B. Weiner

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency

    Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency by David N. Levy, Yosef Refaeli, David B. Weiner

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product.

    The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. by Yosef Refaeli, David N. Levy, David B. Weiner

    Published 1995
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials

    Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials by Devon J. Shedlock, Guido Silvestri, David B. Weiner

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade

    DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade by Malavika S. Giri, Kenneth E. Ugen, David B. Weiner

    Published 2004
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies

    In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies by Ami Patel, Mamadou A. Bah, David B. Weiner

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells

    Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells by Michael A. Chattergoon, Tara M. Robinson, Jean Boyer, David B. Weiner

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr

    Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr by Sundarasamy Mahalingam, Velpandi Ayyavoo, Milloni Patel, Thomas Kieber‐Emmons, David B. Weiner

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1.

    Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. by David N. Levy, Yosef Refaeli, Rob Roy MacGregor, David B. Weiner

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    DNA vaccines for targeting bacterial infections

    DNA vaccines for targeting bacterial infections by Mariana Ingolotti, Omkar U. Kawalekar, Devon J. Shedlock, Kar Muthumani, David B. Weiner

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Immunogenicity of novel consensus-based DNA vaccines against avian influenza

    Immunogenicity of novel consensus-based DNA vaccines against avian influenza by Dominick J. Laddy, Jian Yan, Natasha Corbitt, Darwyn Kobasa, Gary Kobinger, David B. Weiner

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4<sup>+</sup>T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

    DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4<sup>+</sup>T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo by Jeong‐Im Sin, Jong J. Kim, Catherine J. Pachuk, C Satishchandran, David B. Weiner

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab

    Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab by Kar Muthumani, Seleeke Flingai, Megan C. Wise, Colleen Tingey, Kenneth E. Ugen, David B. Weiner

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: